Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myopathy, Inflammatory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04872374
What this trial is testing

Effects of Parmigiano Reggiano on Skeletal Muscle Damage in Older Adults

Who this might be right for
Old Age; AtrophyInflammatory ResponseMuscle Soreness
University of Padova 20
Testing effectiveness (Phase 2)Looking for participantsNCT06347718
What this trial is testing

CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisDermatomyositis+1 more
Miltenyi Biomedicine GmbH 24
Not applicableStudy completedNCT03433079
What this trial is testing

Acute Kidney Injury in Severe Trauma

Who this might be right for
Acute Kidney Injury
University Hospital Ostrava 81
Not applicableUnknownNCT05488327
What this trial is testing

Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis

Who this might be right for
Dermatomyositis
Jiangxi Provincial People's Hopital 10
Early research (Phase 1)Looking for participantsNCT07295847
What this trial is testing

AZD0120 in Autoimmune Diseases

Who this might be right for
Systemic SclerosisIdiopathic Inflammatory MyopathiesRheumatoid Arthritis
AstraZeneca 27
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06821659
What this trial is testing

Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Inflammatory Myopathies+2 more
Peking University Third Hospital 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06665256
What this trial is testing

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

Who this might be right for
Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals 21
Early research (Phase 1)Looking for participantsNCT07236762
What this trial is testing

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis (LN)Sjogren's Syndrome+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Large-scale testing (Phase 3)Looking for participantsNCT04972760
What this trial is testing

Baricitinib in Patients With Relapsing or naïve Dermatomyositis

Who this might be right for
Dermatomyositis
Assistance Publique - Hôpitaux de Paris 62
Early research (Phase 1)Looking for participantsNCT07284797
What this trial is testing

Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases

Who this might be right for
HealthyIdiopathic Inflammatory MyopathiesSystemic Sclerosis+1 more
Xencor, Inc. 60
Not applicableStudy completedNCT05681676
What this trial is testing

Melanocortin Gene Expression in Lymphocytes of Polymyalgia Patients

Who this might be right for
Polymyalgia Rheumatica
Aalborg University 9
Testing effectiveness (Phase 2)Ended earlyNCT02523690
What this trial is testing

Evaluating Muscle Weakness Improvement With Lorcaserin in ICU

Who this might be right for
Muscle WeaknessSepsis
Johns Hopkins University 5
Testing effectiveness (Phase 2)Study completedNCT04208464
What this trial is testing

JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM

Who this might be right for
Idiopathic Inflammatory Myopathies
University of Manchester 15
Testing effectiveness (Phase 2)Study completedNCT02612857
What this trial is testing

Trial of IMO-8400 in Adult Patients With Dermatomyositis

Who this might be right for
Dermatomyositis
Idera Pharmaceuticals, Inc. 30
Post-approval studies (Phase 4)UnknownNCT05505409
What this trial is testing

Efficacy and Safety of Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 120
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Not applicableUnknownNCT06373081
What this trial is testing

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Shanghai Changzheng Hospital 6
Not applicableEnrolling By InvitationNCT07785362
What this trial is testing

Neuro-modulation of Central Pain Pathways in Non Inflammatory Musculoskeletal Pain Syndrome

Who this might be right for
Pain SyndromeFibromyalgiaCRPS (Complex Regional Pain Syndromes)+4 more
Istituto Giannina Gaslini 46
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06888973
What this trial is testing

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisSystemic Lupus Erythematosus (SLE)Systemic Sclerosis+3 more
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 200
Next Page